Clinical Trial Update: A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017

View source ↗

Summary

A clinical trial update using Swedish registries to assess how many people with type 2 diabetes and cardiovascular disease started empagliflozin between 2015 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2021-07-09